The global vascular graft market was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030..
A vascular graft is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting the blood vessels. Vascular grafts are used for the treatment of vascular diseases such as pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins. The incidence of vascular diseases has increased significantly over the last few years. According to the World Health Organization (WHO), an estimated 17.9 million people died from cardiovascular diseases (CVDs) in 2019. Vascular diseases may be caused due to high blood pressure, cholesterol deposition, injury, genetic, and infections.
Vascular grafts are mainly made of polyester, polytetrafluoroethylene (PTFE), and polyurethane material. However, biosynthetic vascular grafts are also available in market. The vascular grafts are classified as hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular stent grafting, or endovascular aneurysm repair (EVAR), is a newer form of treatment for abdominal aortic aneurysm that is less invasive than open surgery. Endovascular stent graft is used to reinforce the wall of the aorta and to help keep the damaged area from rupturing.
The increase in the prevalence of vascular diseases globally drives the growth of vascular grafts market. For instance, according to report by American Heart Association, in 2019, 197.2 million people lived with ischemic heart disease (IHD). In addition, the increase in diabetes and hypertension propels the growth of vascular disease devices market. According to World Health Organization (WHO) in 2021, an estimated 1.28 billion adults aged 30-79 years had hypertension. The older age people are more susceptible to vascular disease and the rise in the geriatric population further contributes in the growth of the vascular grafts market.
In addition, increase in the sedentary lifestyle and unhealthy food eating habits contribute in the growth of the vascular grafts market. However, the high cost of vascular surgery and product failures are expected to limit the growth of the market.
The vascular grafts market is segmented on the basis of product, raw material, end user, and regions. By product, the market is mainly categorized into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular aneurysm repair stent grafts are further subcategorized into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). By raw material, it is categorized in to polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. By end user, it is divided into hospitals and ambulatory surgical centers (ASCs). By Region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation and W. L. Gore & Associates, Inc.
A vascular graft is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting the blood vessels. Vascular grafts are used for the treatment of vascular diseases such as pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins. The incidence of vascular diseases has increased significantly over the last few years. According to the World Health Organization (WHO), an estimated 17.9 million people died from cardiovascular diseases (CVDs) in 2019. Vascular diseases may be caused due to high blood pressure, cholesterol deposition, injury, genetic, and infections.
Vascular grafts are mainly made of polyester, polytetrafluoroethylene (PTFE), and polyurethane material. However, biosynthetic vascular grafts are also available in market. The vascular grafts are classified as hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular stent grafting, or endovascular aneurysm repair (EVAR), is a newer form of treatment for abdominal aortic aneurysm that is less invasive than open surgery. Endovascular stent graft is used to reinforce the wall of the aorta and to help keep the damaged area from rupturing.
The increase in the prevalence of vascular diseases globally drives the growth of vascular grafts market. For instance, according to report by American Heart Association, in 2019, 197.2 million people lived with ischemic heart disease (IHD). In addition, the increase in diabetes and hypertension propels the growth of vascular disease devices market. According to World Health Organization (WHO) in 2021, an estimated 1.28 billion adults aged 30-79 years had hypertension. The older age people are more susceptible to vascular disease and the rise in the geriatric population further contributes in the growth of the vascular grafts market.
In addition, increase in the sedentary lifestyle and unhealthy food eating habits contribute in the growth of the vascular grafts market. However, the high cost of vascular surgery and product failures are expected to limit the growth of the market.
The vascular grafts market is segmented on the basis of product, raw material, end user, and regions. By product, the market is mainly categorized into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular aneurysm repair stent grafts are further subcategorized into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). By raw material, it is categorized in to polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. By end user, it is divided into hospitals and ambulatory surgical centers (ASCs). By Region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation and W. L. Gore & Associates, Inc.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global vascular grafts market size along with the current trends and future estimations to elucidate the imminent investment pockets
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
- A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global vascular grafts market growth
KEY MARKET SEGMENTS
By Product
- Hemodialysis Access Graft
- Endovascular Aneurysm Repair Stent Grafts
- Abdominal Aortic Aneurysm (AAA)
- Thoracic Aortic Aneurysm (TAA)
- Peripheral Vascular Graft
By Raw Material
- Polyester
- Polytetrafluoroethylene (PTFE)
- Polyurethane
- Biosynthetic
By End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- B Braun Melsungen AG
- Becton, Dickinson And Company
- Cook Medical, Inc
- Cordis
- Endologix Inc
- Getinge Group
- LeMaitre Vascular Inc
- Medtronic plc
- Terumo Medical Corporation
- W. L Gore & Associates, Inc
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Landscape
Chapter 4: Vascular Graft Market, by Products
Chapter 5: Vascular Graft Market, by Raw Material
Chapter 6: Vascular Graft Market, by End-user
Chapter 7: Vascular Graft Market, by Region
Chapter 8: Company Profiles
List of Tables
List of Figures
Executive Summary
According to a new report titled, “Vascular Grafts Market by Product and Medication Class: Global Opportunity Analysis and Industry Forecast, 2021–2030, the vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030.Vascular grafting is done for the treatment of various vascular complications, such as coronary artery disease (CAD), pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and pediatric congenital cardiovascular defects (CCDs). The high blood pressure, cholesterol deposition, cardiac injury, and infections are causative factors for vascular diseases. The diabetes, hypertension, obesity, alcohol consumption, and tobacco smoking are the risk factors for the vascular diseases. The synthetic vascular grafts are made up of expanded polytetrafluoroethylene, Dacron, and polyurethane. However, polyurethane is better able to match the compliance of native vasculature. Hemodialysis access grafts, endovascular aneurysm repair stent grafts, and peripheral vascular grafts are commonly used for vascular grafting procedures.
Factors that drive the growth of the vascular grafts market include rise in number of hospitals, increase geriatric population, and advancement in vascular surgeries. For instance, according to World Population Ageing 2019, a publication by United Nation’s Department of Economic and Social Affairs (DESA), 703 million people are aged 65 years or over globally in 2019. Furthermore, surge of sedentary lifestyle and unhealthy food diet has contributed in the growth of market. Sedentary lifestyle is responsible for deposition of cholesterol in blood vessels.
Moreover, increase in prevalence of hypertension has contributed in the growth of vascular grafts market. Hypertension causes damage to the blood vessels as it adds force to the artery walls and over time, this can damage the blood vessels and lead to more plaque buildup. The narrowed artery limits or blocks the blood flow to the heart muscle. For instance, according to World Health Organization (WHO) in 2021, an estimated 1.28 billion adults aged 30-79 years globally had hypertension.
The vascular grafts market is segmented on the basis of product, raw material, end user, and region.
On the basis of product, the vascular grafts market is divided into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. The hemodialysis access graft segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to the prevalence of vascular diseases.
On the basis of raw material, the vascular grafts market is divided into polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. The polyurethane segment dominated the market in 2020, and this trend is expected to continue during the forecast period, due to advantages of polyurethane and better compliance for native vasculature.
On the basis of end users, the market is divided into hospitals and ambulatory surgical centers (ASCs). The hospitals segment dominated the market in 2020, and this trend is expected to continue during the forecast period, due to increase in number of hospitals.
On the basis of region, North America accounted for a majority of the global vascular grafts market share in 2020, and is anticipated to remain dominant during the forecast period due to prevalence of vascular diseases. Asia-Pacific is anticipated to witness lucrative growth, owing to the improvement in healthcare facilities, high population, and government initiatives to provide healthcare service.
Impact of COVID-19 Pandemic on Vascular Graft Market (Pre & Post Analysis)
The COVID-19 outbreak is anticipated to have a negative impact on the growth of the vascular grafts market as most hospitals are not operating due to COVID-19 and the ongoing lockdowns in many countries. The COVID-19 virus has serious and life-threatening impact on patients with cardiac patients. However, a huge number of clinics and hospitals across the globe were restructured to increase the hospital capacity to provide improve healthcare services, and this is expected to increase the diagnosis and surgeries of vascular diseases, which contributes in the market growth.
Key Findings Of Study
- On the basis of products, the hemodialysis access graft segment was the highest contributor to the vascular grafts market in 2020
- On the basis of raw material, the polyurethane segment dominated the market in 2020
- On the basis of end users, the hospitals segment dominated the vascular grafts market in 2020
- On the basis of region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
Companies Mentioned
- B. Braun Melsungen AG
- Becton
- Dickinson And Company
- ook Medical, Inc.
- Cordis
- Endologix Inc.
- Getinge Group
- LeMaitre Vascular Inc.
- Medtronic plc
- Terumo Medical Corporation
- W. L. Gore & Associates, Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 220 |
| Published | February 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 4993.64 million |
| Forecasted Market Value ( USD | $ 8138.68 million |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
